Insiders at Tenet Healthcare (THC) sold $28m of stock on August 25, 2026, disclosed to the SEC on August 26, 2026. The largest was Sutaria Saumya, CEO, at $28m. The stock closed at $271.88 that day, down 2.4%.
That leaves the price near the top of its twelve-month band of $161.37 to $280.77 — 93% of the way up it. The peak itself came 2 sessions ago on August 21, 2026, while the floor dates back to June 4, 2026, 58 sessions ago.
The stock is up 0.6% over five sessions, up 16.6% over a month, up 41.3% over the year. It closed above its thirty-day average price by 11.7%.
Intraday the stock covered 2.5%, in line with its 3.5% thirty-session norm, so the move arrived without unusual swings. The close gave most of it back, settling only 15% up the day's range. It was the 2nd session running lower.
Worth $20bn, the company sits 60 of 128 by size within healthcare. The sector as a whole finished +0.3%, leaning the other way.
From an open of $277.66 the price ranged down to $270.86 and up to $277.66 before closing on $271.88. That is 68.5% above the year's $161.37 floor and 3.2% under its $280.77 ceiling.
Turnover of $270m compares with $326m on an average session for this stock. Against the year, today ranks between the +17.3% best and the -5.7% worst day.
Recent form leans positive: 17 of the last thirty sessions closed up against 13 down. Its strongest single day in the past year was +17.3% on February 11, 2026, its weakest -5.7% on July 14, 2026.
Its size-neighbours in the sector did not follow — Viatris (VTRS) +1.1% and Zimmer Biomet (ZBH) -0.7% — which argues for something particular to this company. THC placed 372th of 986 on money traded.
This text was generated automatically from the closing data. It contains no forecasts and no investment advice — only what the numbers say. Do your own research.